News & Updates

Show Multimedia Only

Abdominal aortic calcification linked to CAD, CI in T2DM

26 Jul 2022

In patients with type 2 diabetes mellitus (T2DM), abdominal aortic calcification might be an important indicator of coronary artery disease (CAD) and cerebral infarction (CI), a new study has found.

Abdominal aortic calcification linked to CAD, CI in T2DM

26 Jul 2022

RAAS inhibitor discontinuation more harmful than beneficial in hyperkalaemic CKD patients

25 Jul 2022

Chronic kidney disease (CKD) patients with hyperkalaemia may fare better with maintaining than discontinuing treatment with a renin-angiotensin-aldosterone system (RAAS) inhibitor, as discontinuation poses risks of higher mortality and increased cardiovascular events, according to a study.

RAAS inhibitor discontinuation more harmful than beneficial in hyperkalaemic CKD patients

25 Jul 2022

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery

24 Jul 2022

For patients undergoing surgery for oesophageal and gastric cancer, cardiopulmonary exercise testing (CPET) appears to be a reliable predictor of major cardiovascular complications, as reported in a study.

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery

24 Jul 2022

Atrial fibrillation ups risk of dementia in seniors

24 Jul 2022

The risk of developing dementia in older adults appears to be elevated in the presence of atrial fibrillation, with some indication of a risk increase already at age <65 years, according to a study.

Atrial fibrillation ups risk of dementia in seniors

24 Jul 2022

Optimizing anticoagulation therapy for atrial fibrillation with prior gastrointestinal bleeding

24 Jul 2022 by

Long-term anticoagulation therapy is often recommended for patients with atrial fibrillation (AF) to reduce their risk of stroke, but gastrointestinal bleeding (GIB) is a common complication that presents a significant challenge. Patients with a history of GIB have heightened risks of recurrent bleeding events, hence interruption or discontinuation of anticoagulants is often warranted. When and how to restart anticoagulant therapy following an episode of GIB has been debated. MIMS Doctor interviewed Dr Pipin Kojodjojo, Cardiologist and Cardiac Electrophysiologist at Asian Heart & Vascular Centre, Singapore, to gather his perspectives on how to manage anticoagulant therapy after a GIB episode.

Optimizing anticoagulation therapy for atrial fibrillation with prior gastrointestinal bleeding

24 Jul 2022

Bilirubin levels inversely associated with new-onset hypertension in perimenopause

23 Jul 2022

Among perimenopausal women, lower total bilirubin concentrations may indicate an increased likelihood of new-onset hypertension, as reported in a cross-sectional study.

Bilirubin levels inversely associated with new-onset hypertension in perimenopause

23 Jul 2022

Increasing cardiac symptoms, healthcare use could be warning signs of sudden cardiac death

23 Jul 2022

In patients with heritable cardiac disease arrhythmogenic right ventricular cardiomyopathy (ARVC), mounting cardiac symptoms and healthcare use seem to precede sudden cardiac death (SCD), a recent study has found.

Increasing cardiac symptoms, healthcare use could be warning signs of sudden cardiac death

23 Jul 2022

Tafamidis still the only approved therapy for ATTR-CM in Asia

23 Jul 2022 by

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating disease with a formidable symptom burden and an average survival of 2–5 years from diagnosis. In 2019, the US Food and Drug Administration approved tafamidis (Vyndamax) as the first disease-modifying therapy for ATTR-CM. Since then, tafamidis has been approved for the treatment of ATTR-CM in over 55 countries including Japan, Australia, and Singapore. MIMS Doctor interviewed Dr Tang Hak Chiaw, consultant cardiologist at Novena Heart Centre, Singapore, about the types and clinical presentation of ATTR-CM in Singapore, and the role of tafamidis in the treatment of this often underdiagnosed and fatal disease of the heart muscle.

Tafamidis still the only approved therapy for ATTR-CM in Asia

23 Jul 2022

Genetic risk score for high SBP does not predict poor hypertension control

22 Jul 2022

Use of a genetic risk score (GRS) for high systolic blood pressure (SBP) does not appear to forecast hypertension control, according to a study.

Genetic risk score for high SBP does not predict poor hypertension control

22 Jul 2022

Prediabetes may up MI, PCI, CABG risk

21 Jul 2022 by

Individuals with prediabetes appear to be at an elevated risk of developing myocardial infarction (MI) as well as requiring coronary interventions, according to a study presented at ENDO 2022.

Prediabetes may up MI, PCI, CABG risk

21 Jul 2022

News & Updates

Filter by Specialty:

Specialty:

Abdominal aortic calcification linked to CAD, CI in T2DM

Abdominal aortic calcification linked to CAD, CI in T2DM

RAAS inhibitor discontinuation more harmful than beneficial in hyperkalaemic CKD patients

RAAS inhibitor discontinuation more harmful than beneficial in hyperkalaemic CKD patients

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery

Atrial fibrillation ups risk of dementia in seniors

Atrial fibrillation ups risk of dementia in seniors

Optimizing anticoagulation therapy for atrial fibrillation with prior gastrointestinal bleeding

Optimizing anticoagulation therapy for atrial fibrillation with prior gastrointestinal bleeding

Bilirubin levels inversely associated with new-onset hypertension in perimenopause

Bilirubin levels inversely associated with new-onset hypertension in perimenopause

Increasing cardiac symptoms, healthcare use could be warning signs of sudden cardiac death

Increasing cardiac symptoms, healthcare use could be warning signs of sudden cardiac death

Tafamidis still the only approved therapy for ATTR-CM in Asia

Tafamidis still the only approved therapy for ATTR-CM in Asia

Genetic risk score for high SBP does not predict poor hypertension control

Genetic risk score for high SBP does not predict poor hypertension control

Prediabetes may up MI, PCI, CABG risk

Prediabetes may up MI, PCI, CABG risk